Gainers
- Ainos, Inc. (NASDAQ:AIMD) shares surged 55.1% to $2.1411 after the company reported results from the additional preclinical study of its low-dose oral interferon formulation against Omicron. The company reported VELDONA formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period.
- F45 Training Holdings Inc. (NYSE:FXLV) shares jumped 43.1% to $3.1350 after a 13D filing showed the company received a non-binding proposal offer by one or more funds for a value of $4 per share.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 39.9% to $8.03. InMed recently reported a FY22 net loss of $33.17 per share.
- SOBR Safe, Inc. (NASDAQ:SOBR) jumped 39.3% to $2.6884 after the company announced it signed three reseller agreements with national distributors.
- MoneyLion Inc. (NYSE:ML) rose 28% to $1.02. MoneyLion responded to Consumer Financial Protection Bureau’s meritless complaint.
- FingerMotion, Inc. (NASDAQ:FNGR) surged 23.1% to $2.2778.
- O2Micro International Limited (NASDAQ:OIIM) rose 22.8% to $3.9901 after the company announced it entered into a definitive agreement for a "going private" transaction.
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares gained 22.6% to $8.89. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
- IGM Biosciences, Inc. (NASDAQ:IGMS) rose 18.9% to $23.11.
- X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) gained 18.8% to $1.77. X4 Pharmaceuticals recently announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
- Benson Hill, Inc. (NYSE:BHIL) rose 18.3% to $2.9250 after UBS initiated coverage on the stock with a Buy rating and $5 price target.
- Tyra Biosciences, Inc. (NASDAQ:TYRA) jumped 17.7% to $10.33.
- Alset EHome International Inc. (NASDAQ:AEI) gained 17.3% to $0.2299.
- Snow Lake Resources Ltd. (NASDAQ:LITM) surged 16.7% to $1.8215. Snow Lake Resources issued filing showing the company has requested for withdrawal of registration statement in regards to its previously announced public offering.
- Nocera, Inc. (NASDAQ:NCRA) jumped 16.2% to $1.58. Nocera recently entered into agreement to acquire 51% controlling interest in iTake Inc. in Taiwan.
- Ecoark Holdings, Inc. (NASDAQ:ZEST) gained 14.8% to $1.47.
- SAI.TECH Global Corporation (NASDAQ:SAI) rose 14.6% to $2.59 after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
- Solid Biosciences Inc. (NASDAQ:SLDB) gained 14.4% to $0.5355 after the company announced acquisition of AavantiBio and a concurrent $75 million private placement.
- Akero Therapeutics, Inc. (NASDAQ:AKRO) rose 14.3% to $34.06. Akero Therapeutics recently released topline data from HARMONY Phase 2b study of efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), fibrosis stage 2 or 3 (F2-F3).
- IonQ, Inc. (NYSE:IONQ) gained 13.3% to $5.41after the company announced it secured a contract to provide quantum solutions to the U.S. Air Force Research Lab.
- Immuneering Corporation (NASDAQ:IMRX) jumped 12.6% to $14.77. Immuneering announced FDA clearance of IND application for Phase 1/2a clinical trial of IMM-1-104 to treat advanced solid tumors with RAS mutations.
- bluebird bio, Inc. (NASDAQ:BLUE) gained 12.2% to $6.39. bluebird bio recently named Katherine Breedis as interim CFO.
- Foghorn Therapeutics Inc. (NASDAQ:FHTX) jumped 11.2% to $9.13.
- MINISO Group Holding Limited (NYSE:MNSO) surged 11% to $5.53. MINISO Group’s board of directors recently authorized and approved a new share repurchase program.
- Daseke, Inc. (NASDAQ:DSKE) gained 10.5% to $5.41 after the company announced a $40 million stock repurchase program.
- Iveda Solutions, Inc. (NASDAQ:IVDA) rose 9.9% to $0.67 after declining over 6% on Thursday. Iveda Solutions, last month, announced a $5 million private placement.
- Kura Oncology, Inc. (NASDAQ:KURA) gained 9.2% to $14.53. Kura Oncology, last month, posted a Q2 loss of $0.52 per share.
- Paysafe Limited (NASDAQ:PSFE) gained 8.8% to $1.48.
- Charles River Laboratories International, Inc. (NYSE:CRL) gained 7.6% to $204.46 after Jefferies upgraded the stock from Hold to Buy and announced a $240 price target.
- WISeKey International Holding AG (NASDAQ:WKEY) rose 7.3% to $1.6101.
- First Wave BioPharma, Inc. (NASDAQ:FWBI) rose 6.2% to $1.54.
